髓源性抑制细胞的生物学功能及其相关抑制剂的研究进展

被引:5
作者
王志宏 [1 ]
陈国江 [2 ]
彭晖 [1 ,3 ]
机构
[1] 中国药科大学基础医学与临床药学学院
[2] 军事科学院军事医学研究院毒物药物研究所
[3] 军事科学院军事医学研究院环境医学与作业医学研究所军事作业医学研究室
关键词
髓源性抑制细胞; 免疫抑制; 癌症免疫治疗;
D O I
10.13220/j.cnki.jipr.2018.01.005
中图分类号
R73-36 [治疗实验];
学科分类号
100214 [肿瘤学];
摘要
髓源性抑制细胞(MDSC)是髓祖细胞和病理状态下积累的未成熟髓细胞组成的异质细胞群。MDSC通过主动抑制T细胞的增殖和细胞毒性,以及促肿瘤形成的T调节细胞(Treg)的增殖从而抑制宿主对肿瘤的免疫应答,此外MDSC还能促进肿瘤血管生成,肿瘤的侵袭和转移,因此又是多种肿瘤的潜在治疗靶点。本综述对MDSC的生物学功能、靶向MDSC的抑制剂及其在肿瘤免疫治疗中的应用进行概述,为癌症免疫治疗提供参考和借鉴。
引用
收藏
页码:25 / 31
页数:7
相关论文
共 15 条
[1]
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities [J].
Kortylewski, Marcin ;
Moreira, Dayson .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (08) :979-988
[2]
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment [J].
Kumar, Vinit ;
Patel, Sima ;
Tcyganov, Evgenii ;
Gabrilovich, Dmitry I. .
TRENDS IN IMMUNOLOGY, 2016, 37 (03) :208-220
[3]
Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity [J].
Toso, Alberto ;
Revandkar, Ajinkya ;
Di Mitri, Diletta ;
Guccini, Ilaria ;
Proietti, Michele ;
Sarti, Manuela ;
Pinton, Sandra ;
Zhang, Jiangwen ;
Kalathur, Madhuri ;
Civenni, Gianluca ;
Jarrossay, David ;
Montani, Erica ;
Marini, Camilla ;
Garcia-Escudero, Ramon ;
Scanziani, Eugenio ;
Grassi, Fabio ;
Pandolfi, Pier Paolo ;
Catapano, Carlo V. ;
Alimonti, Andrea .
CELL REPORTS, 2014, 9 (01) :75-89
[4]
Myeloid‐derived suppressor cell heterogeneity in human cancers.[J].Samantha Solito;Ilaria Marigo;Laura Pinton;Vera Damuzzo;Susanna Mandruzzato;Vincenzo Bronte.Ann. N.Y. Acad. Sci..2014, 1
[5]
Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients.[J].Yazan S. Khaled;Basil J. Ammori;Eyad Elkord;Steven Eric Finkelstein.Journal of Immunology Research.2014,
[6]
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells [J].
Schilling, Bastian ;
Sucker, Antje ;
Griewank, Klaus ;
Zhao, Fang ;
Weide, Benjamin ;
Goergens, Andre ;
Giebel, Bernd ;
Schadendorf, Dirk ;
Paschen, Annette .
INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (07) :1653-1663
[7]
Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences [J].
Pillay, Janesh ;
Tak, Tamar ;
Kamp, Vera M. ;
Koenderman, Leo .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (20) :3813-3827
[8]
Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? [J].
Goh, Celeste ;
Narayanan, Sowmya ;
Hahn, Young S. .
IMMUNOLOGICAL REVIEWS, 2013, 255 (01) :210-221
[9]
Targeting 6-Phosphofructo-2-Kinase ( PFKFB3) as a Therapeutic Strategy against Cancer [J].
Clem, Brian F. ;
O'Neal, Julie ;
Tapolsky, Gilles ;
Clem, Amy L. ;
Imbert-Fernandez, Yoannis ;
Kerr, Daniel A., II ;
Klarer, Alden C. ;
Redman, Rebecca ;
Miller, Donald M. ;
Trent, John O. ;
Telang, Sucheta ;
Chesney, Jason .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) :1461-1470
[10]
Update on the Targeted Therapy of Melanoma [J].
Johnson, Douglas B. ;
Sosman, Jeffrey A. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) :280-292